Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)
- 1 September 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (9), 1457-1461
- https://doi.org/10.1016/0277-5379(88)90336-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Therapeutic activity of ET‐18‐OCH3 and hexadecylphosphocholine against mammary tumors in BD‐VI ratsLipids, 1987
- Cytotoxicity of platelet activating factor and related alkyl- phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblastsBlood, 1984
- INHIBITION BY ALKYL-LYSOPHOSPHOLIPIDS OF TRITIATED-THYMIDINE UPTAKE IN CELLS OF HUMAN-MALIGNANT UROLOGIC TUMORS1981
- INDUCTION OF DIFFERENTIATION OF CULTURED HUMAN AND MOUSE MYELOID-LEUKEMIA CELLS BY ALKYL-LYSOPHOSPHOLIPIDS1981
- The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinomaEuropean Journal of Cancer (1965), 1980
- DISTURBANCE OF PHOSPHOLIPID-METABOLISM DURING THE SELECTIVE DESTRUCTION OF TUMOR-CELLS INDUCED BY ALKYL-LYSOPHOSPHOLIPIDS1979
- Experimentelle Beiträge zum Dosis-Problem in der Krebs-Chemotherapie und zur Wirkungsweise von Endoxan*Deutsche Medizinische Wochenschrift (1946), 1963